Duke University Key Trial Site at Large mRNA COVID-19 Vaccine Study for Children 5 to 11 Years Old

Duke University, one of the most preeminent research centers and trial sites in the United States, helps lead a major clinical trial investigating the two-dose COVID-19 vaccine from Pfizer-BioNTech mRNA vaccine called BNT162b2 in children ages 5 to 11 years of age. Led by pediatrician Dr. Emmanuel Walker, this study coincides with Pfizer’s recent move on Thursday, October 8, 2021, to request emergency use authorization (EUA) for this young age cohort.

Duke University Trial Site

Now that Pfizer is putting together a EUA submission, some prominent participating trial sites go public with observations about the study results. For example, as published in local news Spectrum News 1, the Duke Vaccine and Trials Unit director, Dr. Emmanuel Walker, serves as lead principal investigator.

Principal Investigator Observations

The Study involves the administration of two 10 ug doses of BNT162b2, and according to the led researcher, the “Data…showed the vaccine to be safe and led to an excellent immune response in children.” In comparing dosage and effectiveness, Dr. Walter continued, “The immune response in children was good as that seen for participants in the study, which tested...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee